Complications in Untreated Deep Venous Thrombosis

Main Article Content

Thomas Scott Downs Prado
Viridiana Villanueva Rodríguez

Abstract

Deep venous thrombosis (DVT) is the formation of a thrombus within the deep venous system, most commonly affecting the lower extremities but potentially occurring in other locations such as the pelvis or upper limbs. It constitutes a primary manifestation of venous thromboembolism (VTE) alongside pulmonary embolism (PE), which arises from thrombus migration to the pulmonary arteries. Clinical presentation ranges from limb swelling, pain, erythema, and warmth to asymptomatic cases, making diagnosis reliant on a combination of pretest probability assessment, D-dimer measurement, and confirmatory imaging, typically compression ultrasonography. Major risk factors include surgery, trauma, immobility, malignancy, and thrombophilia. Management is centered on anticoagulation, with direct oral anticoagulants favored for most patients, and advanced interventions reserved for select severe cases. Untreated DVT carries high morbidity and mortality due to complications such as PE, postthrombotic syndrome (PTS), recurrent VTE, sepsis, and, rarely, chronic thromboembolic pulmonary hypertension (CTEPH). Long-term consequences include chronic venous insufficiency, disability, impaired quality of life, and increased mortality risk. Early recognition and timely intervention are critical to reducing complications and improving outcomes.

Article Details

How to Cite
Thomas Scott Downs Prado, and Viridiana Villanueva Rodríguez. 2025. “Complications in Untreated Deep Venous Thrombosis”. International Journal of Medical Science and Clinical Research Studies 5 (08):1414-16. https://doi.org/10.47191/ijmscrs/v5-i08-15.
Section
Articles

References

I. Chopard, R., Albertsen, I. E., & Piazza, G. (2020). Diagnosis and treatment of lower extremity venous thromboembolism: A review. JAMA, 324(17), 1765–1776. https://doi.org/10.1001/jama.2020.17272

II. Cox, C., & Roberts, L. N. (2025). Basics of diagnosis and treatment of venous thromboembolism. Journal of Thrombosis and Haemostasis: JTH, 23(4), 1185–1202. https://doi.org/10.1016/j.jtha.2025.01.009

III. Di Nisio, M., van Es, N., & Büller, H. R. (2016). Deep vein thrombosis and pulmonary embolism. The Lancet, 388(10063), 3060–3073. https://doi.org/10.1016/S0140-6736(16)30514-1

IV. Duffett, L. (2022). Deep venous thrombosis. Annals of Internal Medicine, 175(9), ITC129–ITC144. https://doi.org/10.7326/AITC202209200

V. Ismail, U., Rowe, R. A., Cashin, J., Genin, G. M., & Zayed, M. A. (2022). Multimodal thrombectomy device for treatment of acute deep venous thrombosis. Scientific Reports, 12(1), 5295. https://doi.org/10.1038/s41598-022-09001-6

VI. Khan, F., Tritschler, T., Kahn, S. R., & Rodger, M. A. (2021). Venous thromboembolism. The Lancet, 398(10294), 64–77. https://doi.org/10.1016/S0140-6736(20)32658-1

VII. Streiff, M. B., Brady, J. P., Grant, A. M., et al. (2014). CDC grand rounds: Preventing hospital-associated venous thromboembolism. MMWR. Morbidity and Mortality Weekly Report, 63(9), 190–193.

VIII. Vedantham, S., Sista, A. K., Klein, S. J., et al. (2014). Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. Journal of Vascular and Interventional Radiology: JVIR, 25(9), 1317–1325. https://doi.org/10.1016/j.jvir.2014.04.019